En développement
Santé·03/06/2026Résumé IA
New mRNA vaccine shows promise in reducing skin cancer recurrence
A new mRNA vaccine, Intessemiran Autogen, combined with immunotherapy, has shown a 49% reduction in skin cancer recurrence or death in Stage III/IV patients. The vaccine analyzes tumor mutations to train the immune system.
ا
الشرق الأوسط7 min de lecture
